Catheter Precision invests $1M in Volato Group, receives SOAR and flyExclusive shares

Catheter Precision, Inc.

Purchases 2,941,176 SOAR shares at $0.34/share ($1M) in a private placement.
Volato to deliver 451,901 freely tradeable flyExclusive shares valued at ~$1.1M as additional consideration.
Closing subject to customary conditions including no Material Adverse Effect and NYSE American approval.
Registration Rights Agreement requires Volato to file resale registration statement within 10 days.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Catheter Precision, Inc. entered into Securities Purchase Agreement with Volato Group, Inc. valued at $1,000,000 (effective 2026-06-07).

Action: entry
Agreement: equity purchase
Counterparty: Volato Group, Inc.
Value: $1,000,000
Effective: 2026-06-07

Exact text from the filing

On June 7, 2026, Catheter Precision, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) between Volato Group, Inc. (NYSE American: SOAR), a Delaware corporation (“Volato”), the Company, and other investors party thereto, pursuant to which the Company agreed to purchase 2,941,176 shares of common stock, par value $0.0001 per share, of Volato (“Shares”) at a per share purchase price of $0.34 per share, for an aggregate purchase price of $1,000,000 (the “Subscription Amount”), in a private placement transaction (the “Private Placement”).

View on SEC.gov

745 material agreements filed in the last 30 days. Browse all material agreements →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-019779

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.